PHARMANEWS PARO PRESENTS!
EFFECTS OF STATINS AGAINST DEPRESSION
FIND OUT ABOUT ALL THE NEW DISCOVERIES!
PHARMANEWS PARO #8
Effects of statins against depression Keywords: statins, depression, pharmacy, mechanism
ABBREVIATIONS MDD = Major Depressive Disorder; NSAIDs = nonsteroidal anti-inflammatory drugs; LDL = lowdensity
Introduction Major depressive disorder (MDD) is a serious and often recurrent mental disorder with aprevalence and a lifetime incidence of up to 20% in which it has a high comorbiditywith medical
conditions.
Several
been
studied
lithium,
some and
are
currently
thyroid
used
CRP = C-reactive protein; LFA-1
However,The evidence base for the efficacy of these drug combinations is limited. In
pituitary-adrenal; RCT =
antipsychotics,
and
asantidepressants.
antigen-1; HPA = hypothalamo-
includes
have
lipoprotein; IL = Interleukin;
= leukocyte function
This
drugs
hormones.
addition, theyare often associated with significant side effects, including weight gain, tremor,
nausea,sedation,
and
sometimes
cause
effects
on
the
cardiometabolic
Randomized Clinical Trial;
system.However, statins are generally effective and safer any adverse effects that may
NMDA = Nmethyl-D-aspartate;
occur,even possessing the benefit of lowering cholesterol, an effect that is likely to be
BDNF = brain-derived
beneficialfor a substantial fraction of patients. It is worth mentioning that statins have
neurotrophic factor; HDRS = Hamilton Depression Rating Scale; SSRI = Selective Serotonin Reuptake Inhibitor;
pleiotropiceffects on several (neuro) biological systems that are believed to be involved in theetiopathogenesis synapticplasticity,
of
depression,
oxidative
stress
including and
putative
excitotoxicity
effects in
the
on
neurotransmission,
central
protectiveeffects on the cardiovascular and immunomodulatory effects.
nervous
system,
Mechanism The antidepressant mechanisms of statins could also be related to their effects on atherosclerosis. The presence of lesions in the white matter in the cerebral arteries represents the hallmark of the vascular system. According to the analysis statins can prevent depression, particularly in older people. If statins prevent cerebrovascular changes they can prevent the development of depression. It is worth mentioning that in meta-analysis studies it is suggested that there is an antidepressant effect due to the blockade of the NMDA receptor in patients with depression. Furthermore, statins increase brain- derived neurotrophic factor (BDNF) in the hippocampus and meta-analysis studies have shown that low BDNF is a marker of MDD in humans and that BDNF levels increase with successful treatment. Finally, statins positively regulate the expression of dopamine D1 and D2 receptors in the rat prefrontal cortex, and alterations in D1 and D2 receptors have been associated with the etiology of MDD. In summary, there are several plausible neurobiological effects of statins on inflammation, glucocorticoids, serotonin, NMDA receptors, BDNF, and dopamine receptors that potentially contribute to their antidepressant effects. Many of the proposed "antidepressant" mechanisms of statins, especially those that affect the CNS (eg, neurotransmission, plasticity, and others), are difficult or impossible to study in vivo in humans. Therefore, it will be difficult to
discern
which
of
the
pleiotropic
effects
exerted
by
statins
are
essential
or
necessary
for
an
"antidepressant" effect in humans.
Figure 1: Potential mechanisms explaining antidepressant effects of statins.
With current evidence, it cannot be firmly concluded or refuted that statins have antidepressant effects. Currently, the most promising findings are statins combined with SSRIs in patients with overt MDD. In future studies, it will be very informative to include biomarkers to help understand the mechanisms by which statins could exert their potential antidepressant effect.
All credits of scientific information are for the authors of the scientific article creation! Scientific information reference: Köhler-Forsberg, O., Otte, C., Gold, S. M., & Østergaard, S. D. (2020). Statins in the treatment of depression: Hype or hope? Pharmacology & Therapeutics, 107625. doi:10.1016/j.pharmthera.2020.107625
"Students today, Pharmacists tomorrow"